September 20, 2021Elite Pharmaceuticals Inc /Nv/ • June 29th, 2022 • Pharmaceutical preparations
EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSEDLetter Agreement • June 29th, 2022 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations
This letter agreement (the “Agreement”) shall confirm our understanding as to the terms of your continuing employment with Elite Laboratories, Inc., a Delaware corporation (the “Company”).
EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED SUPPLY & DISTRIBUTION AGREEMENTDistribution Agreement • June 29th, 2022 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations • New York
ELITE PHARMACEUTICALS, INC., with its offices located at 165 Ludlow Avenue, Northvale, New Jersey 07647, United States (“Elite”); and DEXCEL LTD., with its offices located at 1 Dexcel Street, Or Akiva 3060000, Israel (“Dexcel”). Elite and Dexcel are each a “Party” and together are the “Parties”.
September 20, 2021 Lannett Company, Inc.Elite Pharmaceuticals Inc /Nv/ • June 29th, 2022 • Pharmaceutical preparations
EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTHAnd Distribution Agreement • June 29th, 2022 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations • Delaware
THIS LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT is made as of July 20, 2021 (the “Effective Date”), by and between ELITE PHARMACEUTICALS, INC. a Nevada corporation and ELITE LABORATORIES, INC., a Delaware corporation located at 165 Ludlow Avenue, Northvale, New Jersey 07647 (collectively, “ELITE”), and LANNETT COMPANY, INC., USA, a Delaware corporation located at 9000 State Road, Philadelphia, PA 19136 and/or its Affiliates (“LANNETT”).
